Form 4: BioLife Solutions CFO Troy Wichterman Sells Shares to Cover Tax Obligations

BioLife Solutions CFO Troy Wichterman sold 520 shares of common stock on March 21, 2024, at a price of $17.83 per share to cover tax withholding obligations related to vesting restricted stock.

Summary

• On March 21, 2024, Troy Wichterman, the Chief Financial Officer of BioLife Solutions Inc. (BLFS), sold 520 shares of the company's common stock.
• The sale was executed at a price of $17.83 per share.
• Following the transaction, Wichterman directly owns 127,614 shares of BioLife Solutions Inc.
• The sale was conducted under a pre-arranged Rule 10b5-1(c) trading plan adopted on June 19, 2020, to cover tax obligations associated with the vesting of restricted stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction related to tax obligations and doesn't indicate any fundamental change in the company's prospects or the executive's confidence.

Industry Context

This is a routine Form 4 filing related to an insider stock sale. It is common for executives to sell shares to cover tax obligations, especially when restricted stock vests. The use of a pre-arranged Rule 10b5-1 trading plan is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

• Executive compensation packages often include restricted stock units (RSUs) that vest over time.
• Upon vesting, these RSUs are taxed as ordinary income, creating a tax liability for the executive.
• To cover these taxes, executives often sell a portion of their newly vested shares.
• Rule 10b5-1 plans are a common tool used by executives to automate these sales and avoid any appearance of impropriety.
• Companies like Thermo Fisher Scientific and Danaher also see similar filings from their executives related to RSU vesting and tax obligation sales.

Key Dates